Drawing for GENOSCREEN

USPTO serial 79165656

GENOSCREEN

Reviewed by CopyMark Law Group

Reg. 4980234Status 706Renewal
Filing date
Status date
Registration date
Jun 21, 2016
Examiner
EDWARDS, ALICIA COLLINS
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with GENOSCREEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*

Plus Government fees of $3,400

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James J. Bitetto

James J. Bitetto Tutunjian & Bitetto, P.C.401 Broadhollow RoadSuite 402Melville, NY 11747

Goods and services

ClassDescriptionStatusFirst use
001[ Chemicals, other than for use in immunodiagnostics and HIV tests, for use in industry, science, as well as in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; ] chemical preparations for making diagnoses in laboratories other than for medical or veterinary purposes and other than immunodiagnostics and HIV tests; [ chemical reagents, other than those used for medical, veterinary, immunodiagnostic and HIV tests; biological, biochemical, and chemical reagents for non-medical purposes for the improvement of molecules, other than those used for HIV and immunodiagnostics tests; ] biological preparations other than for medical or veterinary use for use for identifying and testing various complex microbiological samples, including human micro biota, soils, water, air and food; chemical products for creating genetic marker libraries in order to genotype a complex micro biota population and for making diagnoses in laboratories other than for medical or veterinary purposes for use in the fields of biology, biotechnology, biochemistry, genomics, proteomics, transcriptomics, genetics and life sciences, other than those used for HIV and immunodiagnostics tests; diagnostic kits comprised of bio chemicals, namely, cells, antibodies, antigens, and gene banks containing bio technologically formed genes, as well as mutation and molecular variant banks containing bio technologically formed genes for in vitro scientific research use and for diagnostics not for medical or veterinary purposesACTIVE
005[ Pharmaceutical products, namely, pharmaceutical products for treatment of cancer, infectious diseases, tuberculosis and for Alzheimer detection and treatment; veterinary products, namely, veterinary products for treatment of cancer, infectious diseases, tuberculosis and Alzheimer detection and treatment; chemical preparations for medical use in the treatment of cancer, infectious diseases, tuberculosis and Alzheimer detection and treatment; ] diagnostic preparations for medical and veterinary use but not for immunodiagnostic and HIV tests; diagnostic products for medical use, namely, reagents and assays [; chemical reagents for medical or veterinary purposes but not for immunodiagnostic and HIV tests; preparations of microorganisms for medical and veterinary use ]ACTIVE
009[ Measuring instruments and devices, namely, research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; computer programs for research and analysis in the fields of science, biology, biotechnology, biochemistry, genomics, proteomics, transcriptomics, genetics, life sciences, cloning, human health, diagnostics and in the processing of biological data; software for scientific analysis of genetic sequences and biological platelets for use in the scientific research industry and in the field of genetics; ] computer programs and software incorporating algorithms designed for research and analysis in the fields of science, biology, biotechnology, biochemistry, genomics, proteomics, transcriptomics, genetics, life sciences, cloning, human health, diagnostics and in the processing of biological data [; computer programs designed for scientific analysis of genetic sequences and biological platelets for use in scientific research; computer programs designed to identify DNA, detect diseases, test and develop drugs; analysis apparatus, not for medical use, namely, scales, sequencers, analyzers and captors; apparatus for testing air, water, food, namely, scales, sequencers, analyzers and captors; chemistry apparatus and instruments, namely, sequencers, chemistry analyzers and captors ;diagnostic apparatus, not for medical use, namely, sequencers, analyzers and captors; electronic quantity indicators for measuring blood and other bodily fluids; measuring instruments, namely, scales, analyzers and captors; DNA chips ]ACTIVE
042Evaluations, analyses, scientific research and technological testing services of flora, metagenomes, microorganisms, micro biota or transcriptomics in the field of [ pharmacy, chemistry, ] biotechnology, [ biochemistry, ] genomics, bacteriology, transcriptomics, genetics, and life sciences; [ biomedical research, and biological, medical and veterinary product development; providing laboratory research services in the field of gene expression and protein profiling, namely, cancer infectious diseases, tuberculosis, Alzheimer biology; ] genotyping services for research and analysis purposes for genotyping based on biological markers; design and development of programming databases in the field of [ pharmaceuticals, ] biotechnology, biology, [ biochemistry, ] genomics, transcriptomics, genetics, and life sciences; clinical laboratory testing services, namely, gene sequencing-based testing services with a view to research relating to genome sequencing of plants and animals, micro-organisms, sequencing of DNA or RNA and epigenetic sequencing; development and updating of computer programs designed for scientific analysis of genetic sequences, genetic sequencing of the genes of individuals and cohorts; [ electronic data storage and computer programming services for publishing data in a computer science environment designed for bioinformatics; bioinformatics computer engineering; laboratory research services in the field of large-scale DNA sequencing; development and updating of data management systems; database design and development applications in general of biological data processing; scientific development and technical validation of micro-satellite and mini-satellite markers; scientific services in the field of genomics for use in laboratories working on all kinds genomes, including human, animal and micro-organisms, namely, scientific development and validation of micro-satellite and mini-satellite markers; ] scientific services in the field of genomics for use in laboratories working on all kinds genomes, including human, animal and micro-organisms, namely, identification, typing, tracing, analysis and creation of a bank and a database, treatments resistance prediction, whole genome sequencing and complete flora; scientific research, mutation detection and identification of microorganisms; [ scientific research, namely, mutation detection and identification of microorganisms; genotyping services for research or analyses purposes; ] development and testing of computer databases, software, algorithms and computing methods for generating and analyzing biological, genetic and epidemiological data [; scientific research and development services in the fields of diagnostic methods, antibody technology, and gene expression systems; rental of software and computer databases; scientific research and development services; medical laboratory services ]ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 11, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 11, 202671AGREGISTERED-SEC.71 ACCEPTED
Aug 24, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 21, 2026ES71TEAS SECTION 71 RECEIVED
Jun 21, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Feb 13, 2025RNWLINTERNATIONAL REGISTRATION RENEWED
Jun 8, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 8, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 8, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 13, 2022NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 13, 2022C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 9, 2022EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Nov 30, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 30, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 30, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 30, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 30, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 30, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 30, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 30, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 9, 2022PUM1OFFICE ACTION ISSUED POU1
Jun 8, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 2, 2022ES75TEAS SECTION 71 & 15 RECEIVED
Jun 21, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 9, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED
Oct 16, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Sep 22, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 22, 2016FIMPFINAL DISPOSITION PROCESSED
Sep 21, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 12, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 21, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 5, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 5, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2016GPNXNOTIFICATION PROCESSED BY IB
Mar 16, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 16, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 16, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 2, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 22, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 30, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2015ALIEASSIGNED TO LIE
Dec 10, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2015RFNTREFUSAL PROCESSED BY IB
Jun 10, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 10, 2015RFRRREFUSAL PROCESSED BY MPU
Jun 8, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 7, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2015MAFRAPPLICATION FILING RECEIPT MAILED
Jun 1, 2015DOCKASSIGNED TO EXAMINER
Jun 1, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 30, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance